Optimizing the Dosing Regimens of Tigecycline against Vancomycin-Resistant Enterococci in the Treatment of Intra-abdominal and Skin and Soft Tissue Infections

Tigecycline was previously considered to have activity against vancomycin-resistant Enterococcus (VRE) isolates, but the optimal dose was not clarified. Thus, this study assessed the in vitro activity of tigecycline against clinical VRE isolates to determine its optimal regimens for complicated intr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Infect Chemother
Hauptverfasser: Santimaleeworagun, Wichai, Hemapanpairoa, Jatapat, Changpradub, Dhitiwat, Thunyaharn, Sudaluck
Format: Artigo
Sprache:Inglês
Veröffentlicht: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2020
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7533206/
https://ncbi.nlm.nih.gov/pubmed/32989939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3947/ic.2020.52.3.345
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge